Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
XH-S003 in PNH
NCT06978699Phase 2Recruiting
- Sponsor
- Infinity Pharmaceuticals, Inc.
- Start
- Apr 2025
- Primary completion
- Aug 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of XH-S003 in paroxysmal nocturnal hemoglobinuria (PNH), sponsored by Infinity Pharmaceuticals, Inc.. Started Apr 2025; status: recruiting.
02
Drugs
XH-S003
03
Conditions
paroxysmal nocturnal hemoglobinuria (PNH)
Beyond the preview
Go deeper on NCT06978699.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06978699.